Jacob M. van Laar

Professor of Rheumatology

University Medical Center Groningen

Netherlands

Research Interests

Explore related searches

Professors in Netherlands Professors in Immunology Immunology professors in Netherlands

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Jacob M. van Laar is a Professor of Rheumatology at the University Medical Center Utrecht, Netherlands. His research focuses on areas such as digital rheumatology, rheumatoid arthritis, systemic sclerosis, and autoimmune rheumatic diseases. Recent publications include studies on treatment targets in early rheumatoid arthritis and mechanisms affecting treatment efficacy in complex autoimmune conditions.

Articles (11)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2020

Year:

2020

Collaborators (8)

Jutta G. Richter

Heinrich-Heine-Universität Düsseldorf Medizinische Fakultät

GERMANY

View details

Antoni Chan

Professor of Rheumatology and Translational Medicine

University of Reading

UNITED KINGDOM

View details

Tom Huizinga

prof

Leiden University Medical Center

NETHERLANDS

View details

Diane van der Woude

Leiden University Medical Center

NETHERLANDS

View details

Michiel van der Vlist

Assistant Professor

University Medical Center Utrecht, Utrecht University

NETHERLANDS

View details

Goos Laverman

University of Twente

NETHERLANDS

View details

Charlotte Teunissen

University of Amsterdam

NETHERLANDS

View details

Marianne Boes

Associate professor

UMC Utrecht

NETHERLANDS

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Jacob M. van Laar

Research Interests

Explore related searches

Contact this professor

About

Articles (11)

Five years of the Digital Rheumatology Network: insights and future directions

HandScan criteria versus ACR/EULAR Boolean remission as treatment target in early rheumatoid arthritis: results of a randomized controlled trial

Dermal cellular senescence and EndMT in patients with systemic sclerosis undergoing cyclophosphamide or aHSCT treatment

Difficult-to-treat rheumatoid arthritis: what have we learned and what do we still need to learn?

Association of autoantibodies with the IFN signature and NETosis in patients with systemic lupus erythematosus

NT-proBNP and sRAGE levels in early rheumatoid arthritis

Identifying relevant determinants of in-hospital time to diagnosis for ANCA-associated vasculitis patients.

Systemic glucocorticoid use and the occurrence of flares in psoriatic arthritis and psoriasis: a systematic review

Mechanisms underlying DMARD inefficacy in difficult-to-treat rheumatoid arthritis: a narrative review with systematic literature search

Revisiting B cell tolerance and autoantibodies in seropositive and seronegative autoimmune rheumatic disease (AIRD).

The role of innate immune cells in systemic sclerosis in the context of autologous hematopoietic stem cell transplantation

Collaborators (8)

Jutta G. Richter

Antoni Chan

Tom Huizinga

Diane van der Woude

Michiel van der Vlist

Goos Laverman

Charlotte Teunissen

Marianne Boes

Make your next move.